Please consult your physician before taking any medication. To be used in patients with liver inflammation and fibrosis. Also indicated in the treatment of pulmonary fibrosis. As a selective cytokine modulating drug such as TNF-a, TGF-beta, PDGF and VEGF, amongst other cytokines KITOSCELL Â® LP Tablets are indicated in conditions that occur with chronic fibrosis associated with tissue damage, such as advanced liver fibrosis or fibrosis lung, where required to prevent, reduce, inhibit or reverse fibrotic lesions. Treatment with LP KITOSCELL Â® Tablets should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of liver fibrosis and / or lung.
Units: 90 Tabs
Route of Administration: Oral